1166 related articles for article (PubMed ID: 19168865)
1. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.
Timmers L; Sluijter JP; van Keulen JK; Hoefer IE; Nederhoff MG; Goumans MJ; Doevendans PA; van Echteld CJ; Joles JA; Quax PH; Piek JJ; Pasterkamp G; de Kleijn DP
Circ Res; 2008 Feb; 102(2):257-64. PubMed ID: 18007026
[TBL] [Abstract][Full Text] [Related]
3. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
4. Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy.
Kawamura N; Kubota T; Kawano S; Monden Y; Feldman AM; Tsutsui H; Takeshita A; Sunagawa K
Cardiovasc Res; 2005 Jun; 66(3):520-9. PubMed ID: 15914117
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury.
Frantz S; Tillmanns J; Kuhlencordt PJ; Schmidt I; Adamek A; Dienesch C; Thum T; Gerondakis S; Ertl G; Bauersachs J
Am J Pathol; 2007 Aug; 171(2):507-12. PubMed ID: 17556593
[TBL] [Abstract][Full Text] [Related]
6. Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II.
Kawano S; Kubota T; Monden Y; Kawamura N; Tsutsui H; Takeshita A; Sunagawa K
Cardiovasc Res; 2005 Sep; 67(4):689-98. PubMed ID: 15921667
[TBL] [Abstract][Full Text] [Related]
7. Borderzone contractile dysfunction is transiently attenuated and left ventricular structural remodeling is markedly reduced following reperfused myocardial infarction in inducible nitric oxide synthase knockout mice.
Gilson WD; Epstein FH; Yang Z; Xu Y; Prasad KM; Toufektsian MC; Laubach VE; French BA
J Am Coll Cardiol; 2007 Oct; 50(18):1799-807. PubMed ID: 17964046
[TBL] [Abstract][Full Text] [Related]
8. Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells.
Maekawa Y; Mizue N; Chan A; Shi Y; Liu Y; Dawood S; Chen M; Dawood F; de Couto G; Li GH; Suzuki N; Yeh WC; Gramolini A; Medin JA; Liu PP
Circulation; 2009 Oct; 120(14):1401-14. PubMed ID: 19770394
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
[TBL] [Abstract][Full Text] [Related]
11. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
[TBL] [Abstract][Full Text] [Related]
12. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
[TBL] [Abstract][Full Text] [Related]
13. Effect of simvastatin on collagen I deposition in non-infarcted myocardium: role of NF-κB and osteopontin.
Zhang J; Xu Y; Pan L; Chen T; Chen Z; Zhao R
Can J Physiol Pharmacol; 2010 Nov; 88(11):1026-34. PubMed ID: 21076490
[TBL] [Abstract][Full Text] [Related]
14. Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction.
Frantz S; Hu K; Bayer B; Gerondakis S; Strotmann J; Adamek A; Ertl G; Bauersachs J
FASEB J; 2006 Sep; 20(11):1918-20. PubMed ID: 16837548
[TBL] [Abstract][Full Text] [Related]
15. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
[TBL] [Abstract][Full Text] [Related]
16. Cell death and proliferation in NF-kappaB p50 knockout mouse after cerebral ischemia.
Li J; Lu Z; Li WL; Yu SP; Wei L
Brain Res; 2008 Sep; 1230():281-9. PubMed ID: 18657523
[TBL] [Abstract][Full Text] [Related]
17. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance.
Saccani A; Schioppa T; Porta C; Biswas SK; Nebuloni M; Vago L; Bottazzi B; Colombo MP; Mantovani A; Sica A
Cancer Res; 2006 Dec; 66(23):11432-40. PubMed ID: 17145890
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
[TBL] [Abstract][Full Text] [Related]
19. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
Kobayashi H; Yasuda S; Bao N; Iwasa M; Kawamura I; Yamada Y; Yamaki T; Sumi S; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
J Cardiovasc Pharmacol; 2009 Dec; 54(6):510-9. PubMed ID: 19755919
[TBL] [Abstract][Full Text] [Related]
20. Tong-xin-luo capsule inhibits left ventricular remodeling in spontaneously hypertensive rats by enhancing PPAR-gamma expression and suppressing NF-kappaB activity.
Bu PL; Zhao XQ; Wang LL; Zhao YX; Li CB; Zhang Y
Chin Med J (Engl); 2008 Jan; 121(2):147-54. PubMed ID: 18272042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
